As of 2025-06-16, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 54.38 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.82 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is 110.6%.
The range of the Relative Valuation is 35.09 - 70.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 23.4x | 15.1x |
| Forward P/E multiples | 17.0x - 21.5x | 19.9x |
| Fair Price | 35.09 - 70.42 | 54.38 |
| Upside | 35.9% - 172.7% | 110.6% |
| Date | P/E |
| 2025-06-12 | 8.80 |
| 2025-06-11 | 8.67 |
| 2025-06-10 | 8.96 |
| 2025-06-09 | 8.86 |
| 2025-06-06 | 8.65 |
| 2025-06-05 | 8.49 |
| 2025-06-04 | 8.61 |
| 2025-06-03 | 8.66 |
| 2025-06-02 | 8.45 |
| 2025-05-30 | 8.56 |
| 2025-05-29 | 8.53 |
| 2025-05-28 | 8.41 |
| 2025-05-27 | 8.50 |
| 2025-05-23 | 8.14 |
| 2025-05-22 | 8.05 |
| 2025-05-21 | 8.04 |
| 2025-05-20 | 8.34 |
| 2025-05-19 | 8.25 |
| 2025-05-16 | 8.27 |
| 2025-05-15 | 8.09 |
| 2025-05-14 | 7.76 |
| 2025-05-13 | 7.95 |
| 2025-05-12 | 8.10 |
| 2025-05-09 | 8.02 |
| 2025-05-08 | 8.20 |
| 2025-05-07 | 8.13 |
| 2025-05-06 | 7.95 |
| 2025-05-05 | 8.36 |
| 2025-05-02 | 8.15 |
| 2025-05-01 | 7.95 |
| 2025-04-30 | 8.12 |
| 2025-04-29 | 8.15 |
| 2025-04-28 | 8.12 |
| 2025-04-25 | 8.05 |
| 2025-04-24 | 8.01 |
| 2025-04-23 | 7.84 |
| 2025-04-22 | 7.97 |
| 2025-04-21 | 7.82 |
| 2025-04-17 | 7.77 |
| 2025-04-16 | 7.65 |
| 2025-04-15 | 7.82 |
| 2025-04-14 | 8.13 |
| 2025-04-11 | 8.04 |
| 2025-04-10 | 7.83 |
| 2025-04-09 | 8.40 |
| 2025-04-08 | 7.91 |
| 2025-04-07 | 8.32 |
| 2025-04-04 | 8.86 |
| 2025-04-03 | 9.07 |
| 2025-04-02 | 9.25 |